Richard Yeh, MBACFO at CStone
Mr. Richard Yeh has over 20 years of experience in investment banks and multinational biopharmaceutical companies. Prior to joining CStone Pharmaceuticals as CFO, Richard was Managing Director and business unit leader of Asia Pacific Healthcare equity research at Goldman Sachs (Asia) L.L.C. in Hong Kong, where he led Goldman Sachs’ research efforts on the Chinese and Asia healthcare markets. Richard was previously head of the regional healthcare research team at Citigroup (HK), focusing on the Chinese healthcare sector, and part of the US research team covering the US biotech sector at Citigroup (US). He began his career in drug discovery research at Amgen, and with the global strategic marketing group at Wyeth. Richard holds an MBA from Cornell University (US) and a
M.Sc. in medical biophysics from the University of Toronto and Ontario Cancer Institute (Canada).